Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide
| Image |  |
|---|---|
| Description | scientific article published in December 2009 |
| Author/s |
author: Daniel H van Raalte Michaela Diamant |
| Publication date | December 1, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |